Maximum residue limit opinions

  • Email
  • Help

This page lists the opinions of the Committee for Medicinal Products for Veterinary Use (CVMP) on maximum residue limit (MRL) evaluations.

The MRL is the maximum concentration of residue accepted by the European Union (EU) in a food product obtained from an animal that has received a veterinary medicine. The assessment of the safety of residues is carried out by the CVMP.

Any MRL opinion issued by the CVMP is published in the first instance as a summary of opinion, in line with the Agency's strategy to improve transparency in the regulatory process. The full opinion is published following the publication of the Commission Regulation formally establishing the MRL status and includes the European public MRL assessment report (EPMAR), which provides more detailed information on the scientific evaluation.

CVMP opinions on MRL evaluations are only published for substances evaluated after the entry into force of Regulation (EC) No 470/2009 on 6 July 2009. For all other substances, the EPMARs (formerly called summary reports) are available.

Back to top

Document(s) Language Status First published Last updated Effective Date
Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits: Fluralaner (English only) adopted 2017-02-17    
Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits: Gamithromycin (English only) adopted 2017-01-12    
Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits: Aluminium salicylate, basic (English only) adopted 2016-12-12    
Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits: Monepantel (English only) adopted 2016-11-16    
Opinion of the Committee for Medicinal Products for Veterinary Use on the establishment of maximum residue limits: Hydrocortisone aceponate (English only) adopted 2016-09-21    
Opinion of the CVMP on the establishment of maximum residue limits: Eprinomectin (English only) adopted 2016-07-07    
Opinion of the CVMP on the establishment of maximum residue limits: Copper carbonate (English only) adopted 2016-05-27    
Opinion of the Committee for CVMP on the establishment of maximum residue limits: Rafoxanide (English only) adopted 2016-05-03    
Opinion of the CVMP on the establishment of maximum residue limits: Gentamicin (English only) adopted 2016-03-22    
Opinion of the CVMP on the establishment of maximum residue limits: Purified semi-solid extract from Humulus lupulus L. containing approximately 48% of beta acids (as potassium salts) (English only) adopted 2016-02-17    
Divergent opinion on maximum residue limits of 'Purified semi-solid extract from Humulus lupulus L. containing approximately 48% of beta acids (as potassium salts)' (English only)   2016-02-17    
Opinion of the CVMP on the establishment of maximum residue limits: Sisapronil (English only) adopted 2015-12-11    
Opinion of the CVMP on the establishment of maximum residue limits: Diethylene glycol monoethyl ether (English only) adopted 2015-10-20    
Opinion of the CVMP on the establishment of maximum residue limits: Aluminium salicylate, basic (English only) adopted 2015-09-17    
Opinion of the CVMP on the establishment of maximum residue limits: Clodronic acid (English only) adopted 2015-09-09    
Opinion of the CVMP on the establishment of maximum residue limits: Hexaflumuron (English only) adopted 2015-09-09    
Opinion of the CVMP on the establishment of maximum residue limits: Propyl 4-hydroxybenzoate and its sodium salt (English only) adopted 2015-09-09    
Opinion of the CVMP on the establishment of maximum residue limits: Tylvalosin (English only) adopted 2015-09-09    
Opinion of the CVMP on the establishment of maximum residue limits: Virginiamycin (English only) adopted 2015-09-09    
Opinion of the CVMP on the establishment of maximum residue limits: Barium selenate (English only) adopted 2015-04-28    
Opinion of the CVMP on the establishment of maximum residue limits: Potassium selenate, sodium selenate, sodium selenite (English only) adopted 2015-04-28    
Opinion of the CVMP on the establishment of maximum residue limits: Tulathromycin (modification of ADI and MRL) (English only) adopted 2015-04-28    
Opinion of the CVMP on the establishment of maximum residue limits: Doxycycline (English only) adopted 2015-03-10    
Opinion of the CVMP on the establishment of maximum residue limits: Gamithromycin (English only) adopted 2015-03-10    
Opinion of the CVMP on the establishment of maximum residue limits: Methylprednisolone (English only) adopted 2015-03-10    
Opinion of the CVMP on the establishment of maximum residue limits: Tulathromycin (English only) adopted 2015-03-10    
Opinion of the CVMP on the establishment of maximum residue limits: Eprinomectin (English only) adopted 2015-02-17    
Opinion of the CVMP on the establishment of maximum residue limits: Lasalocid (English only) adopted 2015-02-17    
Opinion of the CVMP on the establishment of maximum residue limits: Tulathromycin (English only) adopted 2015-02-17    
Opinion of the CVMP on the establishment of maximum residue limits: Lufenuron (English only) adopted 2015-02-04    
Opinion of the CVMP on the establishment of maximum residue limits: Cabergoline (English only) adopted 2014-09-08    
Opinion of the CVMP on the establishment of maximum residue limits: Clorsulon (English only) adopted 2014-09-08    
Opinion of the CVMP on the establishment of maximum residue limits: Closantel (English only) adopted 2014-09-08    
Opinion of the CVMP on the establishment of maximum residue limits: Rafoxanide (English only) adopted 2014-09-08    
Opinion of the CVMP on the establishment of maximum residue limits: Triclabendazole (English only) adopted 2014-09-08    
Opinion of the CVMP on the establishment of maximum residue limits: Ivermectin (English only) adopted 2014-06-17    
Opinion of the CVMP on the establishment of maximum residue limits: Ivermectin (English only) adopted 2014-06-17    
Opinion of the CVMP on the establishment of maximum residue limits: Tildipirosin (English only) adopted 2014-04-14    
Opinion of the CVMP on the establishment of maximum residue limits: Triptorelin acetate (English only) adopted 2014-04-14    
Opinion of the CVMP on the establishment of maximum residue limits: Diclazuril (English only) adopted 2014-03-17    
Opinion of the CVMP on the establishment of maximum residue limits: Butafosfan (English only) adopted 2014-03-17    
Opinion of the CVMP on the establishment of maximum residue limits: Chloroform (English only) adopted 2014-03-17    
Opinion of the CVMP on the establishment of maximum residue limits: Manganese carbonate (English only) adopted 2013-11-27    
Final opinion of the CVMP on the establishment of maximum residue limits: Neomycin (English only) adopted 2013-11-27    
Opinion of the CVMP on the establishment of maximum residue limits: Monepantel (English only) adopted 2013-09-16    
Opinion of the CVMP on the establishment of maximum residue limits: Prednisolone (English only) adopted 2013-07-30    
Opinion of the CVMP on the establishment of maximum residue limits: Double-stranded ribonucleic acid homologous to viral ribonucleic acid coding for part of the coat protein and part of the intergenic region of the Israel acute-paralysis virus (English only) adopted 2013-07-30    
Opinion of the CVMP on the establishment of maximum residue limits: Eprinomectin (English only) adopted 2013-03-21    
Opinion of the CVMP on the establishment of maximum residue limits: Diclazuril (English only) adopted 2013-03-14    
Opinion of the CVMP on the establishment of maximum residue limits: Monensin (English only) adopted 2013-02-08    
Opinion of the CVMP on the establishment of maximum residue limits: Fenbendazole (English only) adopted 2013-01-22    
Opinion of the CVMP on the establishment of maximum residue limits: Phoxim (English only) adopted 2013-01-22    
Opinion of the CVMP on the establishment of maximum residue limits: Sodium salicylate (English only) adopted 2013-01-22    
Opinion of the CVMP on the establishment of maximum residue limits: Azamethiphos (English only) adopted 2012-06-15    
Opinion of the CVMP on the establishment of maximum residue limits: Clorsulon (English only) adopted 2012-06-15    
Opinion of the CVMP on the establishment of maximum residue limits: Pegylated bovine granulocyte colony stimulating factor (English only) adopted 2012-05-25    
Opinion of the CVMP on the establishment of maximum residue limits: Nitroxinil (English only) adopted 2012-05-23    
Opinion of the CVMP on the establishment of maximum residue limits: Closantel (English only) adopted 2012-04-23    
Opinion of the CVMP on the establishment of maximum residue limits: Triclabendazole (English only) adopted 2012-04-13    
Opinion of the CVMP on the establishment of maximum residue limits: Altrenogest (English only) adopted 2012-03-22    
Opinion of the CVMP on the establishment of maximum residue limits: Octenidine dihydrochloride (English only) adopted 2012-03-22    
Opinion of the CVMP on the establishment of maximum residue limits: Phenoxymethylpenicillin (English only) adopted 2012-03-22    
Opinion of the CVMP on the establishment of maximum residue limits: Monepantel (English only) adopted 2012-03-22    
Opinion of the CVMP on the establishment of maximum residue limits: Lasalocid (English only) adopted 2012-03-22    
Opinion of the CVMP on the establishment of maximum residue limits: Methylprednisolone (English only) adopted 2012-03-22    
Opinion of the CVMP on the establishment of maximum residue limits: Isoeugenol (English only) adopted 2011-05-20    
Opinion of the CVMP on the establishment of maximum residue limits: Monepantel (English only) adopted 2011-05-20    
Opinion of the CVMP on the establishment of maximum residue limits: Sodium Salicylate (English only) adopted 2010-11-18    
Opinion of the CVMP on the establishment of maximum residue limits: Derquantel (English only) adopted 2010-11-18    
Opinion of the CVMP on the establishment of maximum residue limits: Tildipirosin (English only) adopted 2010-10-26    
Opinion of the CVMP on the establishment of maximum residue limits: Methylprednisolone (English only) adopted 2010-10-26    
Opinion of the CVMP on the establishment of maximum residue limits: Valnemulin (English only) adopted 2010-10-26